The Generation and Maintenance of Metabolic Alkalosis in Intensive Care Unit

Authors

  • Kreethi Suresh kumar
  • Sivaprakash Vijayarajan
  • Aasini Maria Georgina
  • Varshini Baskaran

DOI:

https://doi.org/10.52783/jns.v14.4179

Keywords:

Metabolic Alkalosis, pH Imbalance, Bicarbonate Excess, Electrolyte Disturbance, Hypokalemia

Abstract

Background: Metabolic alkalosis is a common acid-base disorder in critically ill patients and can contribute to adverse outcomes if not managed appropriately. Understanding its etiology and optimal treatment strategies in the intensive care unit (ICU) is crucial for improving patient care and reducing complications.

Objective: This study aimed to identify the underlying causes of metabolic alkalosis in ICU patients and evaluate the effectiveness of different management approaches in improving patient outcomes.

Materials and Methods: A prospective analysis was conducted in the Critical Care Medicine Department to assess metabolic alkalosis in ICU patients. Data were collected on patient demographics, clinical symptoms, and arterial blood gas (ABG) parameters, including pH, bicarbonate levels, and electrolyte concentrations. The study explored contributing factors such as diuretic use and persistent vomiting. Laboratory investigations, including ABG analysis, serum electrolytes, and renal function tests, were performed to establish correlations between these factors and the development of metabolic alkalosis.

Results: The study included 80 patients, with 61.25% being male and 38.75% female. The most common causes of metabolic alkalosis were diuretic therapy (48.75%) and hemodynamic instability (51.25%). Management primarily involved normal saline administration, with potassium chloride supplementation provided to 50% of hypokalemic patients. Adjustments to diuretic doses were made to prevent further organ dysfunction. ABG monitoring over three days revealed significant improvements in pH (p < 0.001) and bicarbonate levels (p < 0.001).

Conclusion: Effective management of metabolic alkalosis in ICU patients requires a structured approach, including the regulation of diuretic therapy and fluid resuscitation with normal saline. Addressing electrolyte imbalances, particularly hypokalemia and hypochloremia, is essential for patient stabilization and recovery. The successful transfer of 75% of patients to the general ward suggests that appropriate interventions can reduce ICU stays and associated healthcare costs. Implementing these strategies in clinical practice may enhance patient outcomes and optimize resource utilization in ICU settings.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Gillion, V., Jadoul, M., Devuyst, O., & Pochet, J. M. (2018). The patient with metabolic alkalosis. Acta Clinica Belgica, 74(1), 34–40. https://doi.org/10.1080/17843286.2018.1539373

Webster, N. R., & Kulkarni, V. (1999). Metabolic Alkalosis in the Critically III. Critical Reviews in Clinical Laboratory Sciences, 36(5), 497–510. https://doi.org/10.1080/10408369991239286

Brinkman JE, Sharma S. Physiology, Metabolic Alkalosis. In: StatPearls. StatPearls Publishing, Treasure Island (FL); 2023. PMID: 29493916.

Emmett M: Metabolic alkalosis. A brief pathophysiologic review. Clin J Am Soc Nephrol. 2020, 15:1848- 1856. 10.2215/CJN.16041219

Tinawi M. Pathophysiology, Evaluation, and Management of Metabolic Alkalosis. Cureus. 2021 Jan 21;13(1):e12841. doi: 10.7759/cureus.12841. PMID: 33628696; PMCID: PMC7896805.

Do C, Vasquez PC, Soleimani M. Metabolic Alkalosis Pathogenesis, Diagnosis, and Treatment: Core Curriculum 2022. Am J Kidney Dis. 2022;80(4):536-551. doi:10.1053/j.ajkd.2021.12.016

Berg J, Sorensen SA, Ting JT, et al. Human neocortical expansion involves glutamatergic neuron diversification [published correction appears in Nature. 2022 Jan;601(7893):E12. doi: 10.1038/s41586-021-04322-4.]. Nature. 2021;598(7879):151-158. doi:10.1038/s41586-021-03813-8

Park M, Sidebotham D. Metabolic alkalosis and mixed acid-base disturbance in anaesthesia and critical care. BJA Educ. 2023;23(4):128-135. doi:10.1016/j.bjae.2023.01.002

Sood P, Paul G, Puri S. Interpretation of arterial blood gas. Indian J Crit Care Med. 2010 Apr;14(2):57-64. doi: 10.4103/0972-5229.68215. PMID: 20859488; PMCID: PMC2936733.

Gillion, V., Jadoul, M., Devuyst, O., & Pochet, J.-M. (2018). The patient with metabolic alkalosis. Acta Clinica Belgica, 74(1), 34–40. https://doi.org/10.1080/17843286.2018.1539373

Chebib, F. T. (2017). Metabolic Alkalosis. DeckerMed Nephrology, Dialysis, and Transplantation. https://doi.org/10.2310/nephro.12002

Bardak, S., Kıykım, A., Esen, K., Turgutalp, K., Demir, S., Bircan Özdoğan, A., & Özcan Kara, P. (2016). Recurrent Hypokalemia, Hypomagnesemia and Metabolic Alkalosis Following Preemptive Renal Transplantation: Bartter Syndrome. Turkish Nephrology Dialysis Transplantation, 25(03). https://doi.org/10.5262/tndt.2016.1003.23

Tripathy S. Extreme metabolic alkalosis in intensive care. Indian J Crit Care Med. 2009;13(4):217-220. doi:10.4103/0972-5229.60175

Mccauley, M., Gunawardane, M., & Cowan, M. J. (2006). Severe Metabolic Alkalosis due to Pyloric Obstruction: Case Presentation, Evaluation, and Management. The American Journal of the Medical Sciences, 332(6), 346–350. doi:10.1097/00000441-200612000-00007

Renaud CJ, Ng WP. Conventional bicarbonate haemodialysis in postgastrectomy metabolic alkalosis. Singapore Med J. 2008;49:e121–2. [PubMed] [Google Scholar]

Kirsch BM, Sunder-Plasmann G, Schwarz C. Metabolic alkalosis in a hemodialysis patient-successful treatment with a proton pump inhibitor. Clin Nephrol. 2006;66:391–4. doi: 10.5414/cnp66391. [DOI] [PubMed] [Google Scholar]

Downloads

Published

2025-04-21

How to Cite

1.
kumar KS, Vijayarajan S, Georgina AM, Baskaran V. The Generation and Maintenance of Metabolic Alkalosis in Intensive Care Unit. J Neonatal Surg [Internet]. 2025Apr.21 [cited 2025Oct.18];14(15S):1932 1939. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/4179